LPL Financial LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$323,000
+14.5%
3,747
+18.4%
0.00%
Q2 2022$282,000
-10.8%
3,164
+12.6%
0.00%
Q1 2022$316,000
-35.6%
2,810
-11.5%
0.00%
Q4 2021$491,000
+16.1%
3,176
+4.7%
0.00%
Q3 2021$423,000
+16.5%
3,033
+9.6%
0.00%
Q2 2021$363,000
-10.8%
2,767
+3.5%
0.00%
Q1 2021$407,000
+102.5%
2,673
+38.6%
0.00%
Q4 2019$201,000
-7.4%
1,929
-11.7%
0.00%
Q3 2019$217,000
-34.6%
2,185
-10.7%
0.00%
-100.0%
Q4 2018$332,000
-85.3%
2,446
-70.2%
0.00%
-80.0%
Q3 2018$2,251,000
+234.0%
8,200
+152.0%
0.01%
+150.0%
Q2 2018$674,000
+20.8%
3,254
-20.2%
0.00%0.0%
Q4 2017$558,000
-3.3%
4,078
-3.8%
0.00%0.0%
Q3 2017$577,000
+19.0%
4,237
+6.0%
0.00%0.0%
Q2 2017$485,000
-15.2%
3,999
-26.2%
0.00%
-50.0%
Q1 2017$572,000
+23.0%
5,417
+19.3%
0.00%0.0%
Q4 2016$465,000
+21.1%
4,539
+18.8%
0.00%0.0%
Q3 2016$384,000
-20.3%
3,822
-1.9%
0.00%0.0%
Q2 2016$482,000
+79.2%
3,898
+60.7%
0.00%
+300.0%
Q1 2016$269,000
-68.9%
2,426
-85.1%
0.00%
-80.0%
Q4 2014$864,00016,2420.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders